Right Gastroepiploic Artery Graft: Long-Term Clinical Follow-Up in 271 Patients?Experience of a Single Center

Formica, Francesco; Greco, Pierpaolo; Colagrande, Luisa; Martino, Antonello Stefano; Corti, Fabrizio; Ferro, Orazio; Paolini, Giovanni

doi:10.1111/j.1540-8191.2006.00292.x

Cited by 4 publications

(8 citation statements)

References 27 publications

(55 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other groups have also adopted this graft in large series of patients with good clinical and angiographical results [20], and in association with both internal thoracic arteries [12,21]. In the same year, Puig et al [17] demonstrated the viability of using the inferior epigastric artery in another effort to increment the utilization of arterial arteries in CABG.…”

Section: -Estimated Probability Free From Re-interventionmentioning

confidence: 99%

Seguimento a longo prazo de pacientes submetidos à revascularização do miocárdio com uso exclusivo de enxertos arteriais

Abdouni¹,

Lisboa²,

Puig³

et al. 2008

Rev Bras Cir Cardiovasc

View full text Add to dashboard Cite

Seguimento a longo prazo de pacientes submetidos à revascularização do miocárdio com uso exclusivo de enxertos arteriaisLong-term follow-up of patients undergone coronary artery bypass grafting with exclusive use of arterial grafts Abstract Objective: To evaluate the long-term results of coronary artery bypass grafting with the exclusive use of arterial grafts for patients with triple vessel disease.Methods: We evaluated 136 patients who underwent isolated coronary artery bypass grafting between January 1995 and December 1997. A total of 353 grafts were used for revascularization of 449 arteries (mean: 3.30 per patient). Grafts used were the left internal thoracic artery (99.2%), right internal thoracic artery (56.6%), radial artery (87.5%), right gastroepiploic artery (20.5%) and one inferior epigastric artery. Seventy-six (55.8%) patients received composite grafts ("Y-shape") and 66 (48.5%) patients received sequential anastomoses.Results: Hospital mortality was 4.4%. In the long-term follow-up (9.5 to 12.8 years), 82.1% of the patients were free of cardiac events. Twenty (17.9%) patients had hospital readmission due to cardiac events: 15 presented angina and five presented acute myocardial infarction, with three of them presenting with associated heart failure. Eight (7.1%) patients needed coronary re-interventions: one underwent coronary bypass reoperation and the others underwent coronary angioplasty with stent implantation. Estimated probability of being event-free was 98.2%, 95.4% and 84.2% at 1, 5 and 10 years of follow-up respectively. There were 16 (14.2%) late deaths with four of them (3.6%) being cardiacrelated. Actuarial 12.8-year survival of all types of death was 85% in this group.Conclusion: Coronary artery bypass grafting with the exclusive use of arterial grafts is a safe procedure for patients with triple vessel coronary disease with good long-term results.Descriptors: Myocardial revascularization. Arteriosclerosis/ surgery. Mammary arteries. Radial artery. ResumoObjetivo: Avaliar os resultados a longo prazo da cirurgia de revascularização do miocárdio com o uso exclusivo de enxertos arteriais em pacientes com doença coronariana triarterial.

show abstract

Section: -Estimated Probability Free From Re-interventionmentioning

confidence: 99%

Seguimento a longo prazo de pacientes submetidos à revascularização do miocárdio com uso exclusivo de enxertos arteriais

Abdouni¹,

Lisboa²,

Puig³

et al. 2008

Rev Bras Cir Cardiovasc

View full text Add to dashboard Cite

show abstract

“…Hirose et al mentioned that the RGEA can be dilated from 1.5 mm to 2.0 mm to 2.5 mm by papaverine injection 19 . Formica et al used glyceryl‐verapamil solution as well as papaverine 30 …”

Section: Methodsmentioning

confidence: 99%

“…Many surgeons have been using papeverine externally or intraluminally to relieve spasm when harvesting the RGEA. 19,23,[28][29][30][31][32][33][34][35][36][37][38] Hirose et al mentioned that the RGEA can be dilated from 1.5 mm to 2.0 mm to 2.5 mm by papaverine injection. 19 Formica et al used glyceryl-verapamil solution as well as papaverine.…”

Section: Spasm Of Rgeamentioning

confidence: 99%

“…19 Formica et al used glyceryl-verapamil solution as well as papaverine. 30 Chavanon reported the effect of external application of topical vasodilators to the RGEA when measuring blood flow comparing papaverine, linsidomine, nicardipine, glyceryl trinitrate, and normal saline solution, with the result that glyceryl trinitrate and papaverine, to a lesser extent, were more effective than the others as topical vasodilators. 37 More recently, some investigators have been using phosphodiesterase-3 (PDE-3) inhibitors.…”

Section: Spasm Of Rgeamentioning

confidence: 99%

“…When the RGEA is used, the severity of the targeted coronary artery stenosis should usually be greater than 90%, because of concerns about competitive flow between the native coronary artery and the graft. 30,31,[41][42][43] Mild stenosis (less than 70%) is not thought to be ideal to use the RGEA, as some authors pointed out in their angiographic studies. 42,44 Also, runoff of the native coronary artery is important.…”

Section: Distal Anastomosis Of Rgeamentioning

confidence: 99%

See 2 more Smart Citations

The Right Gastroepiploic Artery in Coronary Artery Bypass Grafting

Sasaki

2008

Journal of Cardiac Surgery

View full text Add to dashboard Cite

The right gastroepiploic artery (RGEA) has been used as a conduit in coronary artery bypass grafting. Although some reports presenting good results justify its use in clinical settings, there is still much concern about using the RGEA in bypass surgery. The RGEA demonstrates different behaviors from the internal thoracic artery (ITA) in bypass surgery due to its histological characteristics and anatomical difference, which might contribute to the long-term outcome. Now that left ITA (LITA) to left anterior descending artery (LAD) is the gold standard, other grafts are expected to cover the rest of the coronary arteries. It should be elucidated how we can use other grafts and what we can expect from them. RGEA, as an arterial graft, can be used as an in situ graft or a free graft. The RGEA is mainly used to graft to the right coronary artery (RCA) because of its anatomical position, and its patency is not inferior to that of the saphenous vein (SVG). The RGEA can cover the lateral walls when its length is long enough or by making a composite graft with other grafts. However, when used to graft to the LAD, its mid-term patency is not favorable.

show abstract

The impact of the radial artery or the saphenous vein in addition to the bilateral internal mammary arteries on late survival: A propensity score analysis

Formica

D’Alessandro

Singh

et al. 2019

The Journal of Thoracic and Cardiovascular Surgery

Self Cite

View full text Add to dashboard Cite

Background: Long-term survival benefits of full arterial revascularization with radial artery (RA) used in addition to bilateral internal mammary arteries (BIMA) compared with saphenous vein (SV) used in addition to BIMA has not been clearly defined.Methods: We retrospectively analyzed 660 3-vessel coronary artery disease subjects who received BIMA in addition to either RA (n ¼ 206) or SV (n ¼ 454) grafting in a period between June 1999 and November 2017. After propensity score matching, we obtained 190 matched pairs for analysis.

show abstract

Right Gastroepiploic Artery Graft: Long-Term Clinical Follow-Up in 271 Patients?Experience of a Single Center

Cited by 4 publications

References 27 publications

Seguimento a longo prazo de pacientes submetidos à revascularização do miocárdio com uso exclusivo de enxertos arteriais

Seguimento a longo prazo de pacientes submetidos à revascularização do miocárdio com uso exclusivo de enxertos arteriais

The Right Gastroepiploic Artery in Coronary Artery Bypass Grafting

The impact of the radial artery or the saphenous vein in addition to the bilateral internal mammary arteries on late survival: A propensity score analysis

Contact Info

Product

Resources

About